These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35592415)

  • 1. Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis.
    Dutta T; Anand U; Mitra SS; Ghorai M; Jha NK; Shaikh NK; Shekhawat MS; Pandey DK; Proćków J; Dey A
    Front Pharmacol; 2022; 13():827411. PubMed ID: 35592415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbal medicines in the treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD): An updated systematic review of clinical trials.
    Golsorkhi H; Qorbani M; Sabbaghzadegan S; Dadmehr M
    Avicenna J Phytomed; 2023; 13(4):338-353. PubMed ID: 37663386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): A systematic review.
    Anheyer D; Lauche R; Schumann D; Dobos G; Cramer H
    Complement Ther Med; 2017 Feb; 30():14-23. PubMed ID: 28137522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence.
    Sarris J; Kean J; Schweitzer I; Lake J
    Complement Ther Med; 2011 Aug; 19(4):216-27. PubMed ID: 21827936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Phytotherapy for attention deficit hyperactivity disorder (ADHD): a systematic review and meta-analysis.
    Dutta T; Anand U; Mitra SS; Ghorai M; Jha NK; Shaikh NK; Shekhawat MS; Pandey DK; Proćków J; Dey A
    Front Pharmacol; 2024; 15():1365806. PubMed ID: 38549676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iranian Traditional Medicine for Treatment of Attention Deficit Disorder with Hyperactivity in Children: A Systematic Review of Randomized Controlled Trials.
    Noorazar SG; Mirzaei M; Kalejahi P
    Iran J Public Health; 2024 Feb; 53(2):280-292. PubMed ID: 38894827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
    PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.
    He S; Wang M; Si J; Zhang T; Cui H; Gao X
    BMJ Open; 2018 Feb; 8(2):e020434. PubMed ID: 29463592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled, trial.
    Shakibaei F; Radmanesh M; Salari E; Mahaki B
    Complement Ther Clin Pract; 2015 May; 21(2):61-7. PubMed ID: 25925875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD).
    Pellow J; Solomon EM; Barnard CN
    Altern Med Rev; 2011 Dec; 16(4):323-37. PubMed ID: 22214252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. East asian herbal medicine for the treatment of children with attention deficit hyperactivity disorder: A Systematic Review and Meta-analysis.
    Lee JH; Jo HG; Min SY
    Explore (NY); 2023; 19(3):330-355. PubMed ID: 36463095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Medication for Attention-Deficit Hyperactivity Disorder in Children and Adolescents with Common Comorbidities: A Systematic Review.
    Tsujii N; Usami M; Naya N; Tsuji T; Mishima H; Horie J; Fujiwara M; Iida J
    Neurol Ther; 2021 Dec; 10(2):499-522. PubMed ID: 34089145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children.
    Dave UP; Dingankar SR; Saxena VS; Joseph JA; Bethapudi B; Agarwal A; Kudiganti V
    Adv Mind Body Med; 2014; 28(2):10-5. PubMed ID: 24682000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.
    Storebø OJ; Elmose Andersen M; Skoog M; Joost Hansen S; Simonsen E; Pedersen N; Tendal B; Callesen HE; Faltinsen E; Gluud C
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008223. PubMed ID: 31222721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
    Sarris J; McIntyre E; Camfield DA
    CNS Drugs; 2013 Apr; 27(4):301-19. PubMed ID: 23653088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Mayhew AD; Page MJ; Ridao M; Tobías A; Catalá MA; Tabarés-Seisdedos R; Moher D
    Syst Rev; 2015 Feb; 4():19. PubMed ID: 25875125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.